You are here

Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept

Last updated on February 28, 2019

FOR MORE INFORMATION
Study Location
Centre Hopitalier St Jacques (Place St Jacques)
Besancon, , 25030 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Eighteen (18) years of age or older at the time of consent.

- Previously treated with etanercept for chronic plaque psoriasis for at least 12 weeks
prior to the screening visit and received a total weekly dose of 50 mg per week for at
least the 6 weeks preceding the day of the screening visit

- Having shown clinical response with a PGA inferior or equal to 1 at the screening
visit.

- PGA inferior or equal to 1 at the baseline visit.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence of skin conditions (eg, eczema) other than psoriasis that would interfere
with evaluations of the effect of study medication on psoriasis.

- Evidence of active or previously known medical history of inflammatory arthritis (eg,
rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis).

- Any biologics other than etanercept within the 20 weeks prior to the screening visit.

NCT00992394
Pfizer
Completed
Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now